Reverse payment settlement agreements are under scrutiny in the US. Martin B Pavane and Lisa A Ferrari of Cohen Pontani Lieberman & Pavane LLP in New York explain why, and provide advice on how pharmaceutical companies can avoid investigation
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
Morgan Lewis snags Duane Morris patent team; Purdue University drops smartphone suit against Google; Meta faces $175m bill over voice comms patents; Vans wants ‘Old Skool’ parody off market; SG wants SCOTUS review on TM extraterritoriality; Netflix drops Bridgerton musical case